120 related articles for article (PubMed ID: 32032904)
1. Lactoferrin/Hyaluronic acid double-coated lignosulfonate nanoparticles of quinacrine as a controlled release biodegradable nanomedicine targeting pancreatic cancer.
Etman SM; Abdallah OY; Mehanna RA; Elnaggar YSR
Int J Pharm; 2020 Mar; 578():119097. PubMed ID: 32032904
[TBL] [Abstract][Full Text] [Related]
2. Undaria pinnatifida fucoidan nanoparticles loaded with quinacrine attenuate growth and metastasis of pancreatic cancer.
Etman SM; Mehanna RA; Bary AA; Elnaggar YSR; Abdallah OY
Int J Biol Macromol; 2021 Feb; 170():284-297. PubMed ID: 33340624
[TBL] [Abstract][Full Text] [Related]
3. Targeted tumor delivery and controlled release of neuronal drugs with ferritin nanoparticles to regulate pancreatic cancer progression.
Lei Y; Hamada Y; Li J; Cong L; Wang N; Li Y; Zheng W; Jiang X
J Control Release; 2016 Jun; 232():131-42. PubMed ID: 27046157
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronate/lactoferrin layer-by-layer-coated lipid nanocarriers for targeted co-delivery of rapamycin and berberine to lung carcinoma.
Kabary DM; Helmy MW; Elkhodairy KA; Fang JY; Elzoghby AO
Colloids Surf B Biointerfaces; 2018 Sep; 169():183-194. PubMed ID: 29775813
[TBL] [Abstract][Full Text] [Related]
5. Development of inhalable quinacrine loaded bovine serum albumin modified cationic nanoparticles: Repurposing quinacrine for lung cancer therapeutics.
Vaidya B; Kulkarni NS; Shukla SK; Parvathaneni V; Chauhan G; Damon JK; Sarode A; Garcia JV; Kunda N; Mitragotri S; Gupta V
Int J Pharm; 2020 Mar; 577():118995. PubMed ID: 31935471
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
[TBL] [Abstract][Full Text] [Related]
7. Hyaluronic acid ion-pairing nanoparticles for targeted tumor therapy.
Li W; Yi X; Liu X; Zhang Z; Fu Y; Gong T
J Control Release; 2016 Mar; 225():170-82. PubMed ID: 26826304
[TBL] [Abstract][Full Text] [Related]
8. Synergistic inhibition of migration and invasion of breast cancer cells by dual docetaxel/quercetin-loaded nanoparticles via Akt/MMP-9 pathway.
Li J; Zhang J; Wang Y; Liang X; Wusiman Z; Yin Y; Shen Q
Int J Pharm; 2017 May; 523(1):300-309. PubMed ID: 28336457
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronic acid coated PLGA nanoparticulate docetaxel effectively targets and suppresses orthotopic human lung cancer.
Wu J; Deng C; Meng F; Zhang J; Sun H; Zhong Z
J Control Release; 2017 Aug; 259():76-82. PubMed ID: 28027947
[TBL] [Abstract][Full Text] [Related]
10. Double-Cross-Linked Hyaluronic Acid Nanoparticles with pH/Reduction Dual-Responsive Triggered Release and pH-Modulated Fluorescence for Folate-Receptor-Mediated Targeting Visualized Chemotherapy.
Zhao X; Jia X; Liu L; Zeng J; Tian K; Zhou T; Liu P
Biomacromolecules; 2016 Apr; 17(4):1496-505. PubMed ID: 27010934
[TBL] [Abstract][Full Text] [Related]
11. Novel fucoidan based bioactive targeted nanoparticles from Undaria Pinnatifida for treatment of pancreatic cancer.
Etman SM; Abdallah OY; Elnaggar YSR
Int J Biol Macromol; 2020 Feb; 145():390-401. PubMed ID: 31881303
[TBL] [Abstract][Full Text] [Related]
12. Magnetic bio-metal-organic framework nanocomposites decorated with folic acid conjugated chitosan as a promising biocompatible targeted theranostic system for cancer treatment.
Nejadshafiee V; Naeimi H; Goliaei B; Bigdeli B; Sadighi A; Dehghani S; Lotfabadi A; Hosseini M; Nezamtaheri MS; Amanlou M; Sharifzadeh M; Khoobi M
Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():805-815. PubMed ID: 30889755
[TBL] [Abstract][Full Text] [Related]
13. Mithramycin-loaded mPEG-PLGA nanoparticles exert potent antitumor efficacy against pancreatic carcinoma.
Liu XJ; Li L; Liu XJ; Li Y; Zhao CY; Wang RQ; Zhen YS
Int J Nanomedicine; 2017; 12():5255-5269. PubMed ID: 28769562
[TBL] [Abstract][Full Text] [Related]
14. Rationally designed hyaluronic acid-based nano-complexes for pentamidine delivery.
Carton F; Chevalier Y; Nicoletti L; Tarnowska M; Stella B; Arpicco S; Malatesta M; Jordheim LP; Briançon S; Lollo G
Int J Pharm; 2019 Sep; 568():118526. PubMed ID: 31323370
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronic acid functional amphipathic and redox-responsive polymer particles for the co-delivery of doxorubicin and cyclopamine to eradicate breast cancer cells and cancer stem cells.
Hu K; Zhou H; Liu Y; Liu Z; Liu J; Tang J; Li J; Zhang J; Sheng W; Zhao Y; Wu Y; Chen C
Nanoscale; 2015 May; 7(18):8607-18. PubMed ID: 25898852
[TBL] [Abstract][Full Text] [Related]
16. Sensitization of A-549 lung cancer cells to Cisplatin by Quinacrine-loaded lipidic nanoparticles via suppressing Nrf2 mediated defense mechanism.
Ahmadian S; Sabzichi M; Rashidi M; Mohammadian J; Mahmoudi S; Maroufi NF; Ramezani F; Ghorbani M; Mohammadi M; Pirouzpanah M; Bijanpour H
Naunyn Schmiedebergs Arch Pharmacol; 2021 Jul; 394(7):1521-1528. PubMed ID: 33735393
[TBL] [Abstract][Full Text] [Related]
17. Fucoidan/hyaluronic acid cross-linked zein nanoparticles loaded with fisetin as a novel targeted nanotherapy for oral cancer.
Moustafa MA; El-Refaie WM; Elnaggar YSR; El-Mezayen NS; Awaad AK; Abdallah OY
Int J Biol Macromol; 2023 Jun; 241():124528. PubMed ID: 37086764
[TBL] [Abstract][Full Text] [Related]
18. Cysteine-based redox-responsive nanoparticles for small-molecule agent delivery.
Wang L; You X; Lou Q; He S; Zhang J; Dai C; Zhao M; Zhao M; Hu H; Wu J
Biomater Sci; 2019 Oct; 7(10):4218-4229. PubMed ID: 31389415
[TBL] [Abstract][Full Text] [Related]
19. Novel hyaluronic acid-modified temperature-sensitive nanoparticles for synergistic chemo-photothermal therapy.
Zhao T; Qin S; Peng L; Li P; Feng T; Wan J; Yuan P; Zhang L
Carbohydr Polym; 2019 Jun; 214():221-233. PubMed ID: 30925992
[TBL] [Abstract][Full Text] [Related]
20. Lactoferrin bioconjugated solid lipid nanoparticles: a new drug delivery system for potential brain targeting.
Singh I; Swami R; Pooja D; Jeengar MK; Khan W; Sistla R
J Drug Target; 2016; 24(3):212-23. PubMed ID: 26219519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
